Medicine & TechnologyResearchers are currently developing a drug for COVID-19 treatment and its Phase II trial has verified a high 90-percent success in recovery rate. Patients participating in the study recovered within days.
Scientists debate the use of low dose radiation therapy for patients with severe coronavirus. Some argue that clinical trials are outdated, while some believe it can alleviate cytokine storms.
COVID-19 patients with severe cases often suffer from organ damage and sometimes death. But a team of scientists has proposed a novel way of limiting organ damage to improve outcomes for severe cases of the disease.
Scientists from the John Hopkins University School of Medicine are recruiting participants for their clinical trial involving prazosin, an alpha-blocker drug, to be used in the treatment of mild to moderate cases of coronavirus in patients. They are hopeful that if the drug proves to be safe and effective for use, it could help numerous people recover safely from home.